HIPAA and AI: What Healthcare Marketers Should Know

Healthcare marketers can use AI only in ways that protect patient information and comply with HIPAA when the organization and activity are covered by the law. The key is to know whether data is protected health information (PHI), who is handling it, and whether the tool and workflow have the required safeguards and agreements—not simply whether a vendor says its product is “HIPAA compliant.”

How HIPAA applies to marketing

The Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, and Breach Notification Rules govern covered entities and, in many circumstances, their business associates. Covered entities include most health plans, healthcare clearinghouses, and healthcare providers that conduct certain electronic transactions. A business associate performs services involving PHI on behalf of a covered entity, such as operating a system that stores or processes patient information.

HIPAA does not regulate every company that markets health-related products, nor does it make all health information PHI. PHI is individually identifiable health information held or transmitted by a covered entity or business associate, subject to the law’s definitions and exceptions. A patient’s name linked to a diagnosis or appointment information can be PHI in a covered organization’s marketing system. Generic educational content with no identifiable patient information generally is not PHI.

Marketing has a specific meaning under HIPAA. Some communications about a covered entity’s own services or treatment may fall outside that definition, while other communications that encourage purchase or use of a product or service can require written authorization. The rules have exceptions, and the facts matter. Marketers should not assume that a campaign is permissible merely because it is educational, sent to existing patients, or produced with AI.

What changes when AI is involved

AI does not create a separate HIPAA exemption. The same privacy and security obligations apply when staff use generative AI to draft copy, summarize records, segment audiences, generate images, answer patient questions, or analyze campaign performance. The risk depends on the data entered, how the system processes it, and what happens to the output.

For example, asking an unapproved public chatbot to rewrite a message that includes a patient’s name, treatment, and appointment date may disclose PHI to the service. Removing names alone may not be enough: dates, locations, rare conditions, or other details can make someone identifiable. Conversely, asking an approved tool to draft a general article about preventive care using no patient-specific information may not involve PHI at all.

AI systems can also create privacy risks without receiving an obvious patient record. A model or analytics tool may infer sensitive characteristics from browsing, location, or engagement patterns. Marketers should assess the actual data flows and capabilities, rather than treating “AI” as a single, uniform technology.

Business associates and vendor review

If an AI vendor creates, receives, maintains, or transmits PHI on behalf of a covered entity, it may be a business associate. The covered entity generally must have a written business associate agreement (BAA) with that vendor before the vendor handles PHI, unless a specific exception applies. A BAA sets out permitted uses and disclosures and requires safeguards, among other obligations.

A BAA is important, but it does not by itself make a tool or campaign safe or lawful. Before approving a product, privacy, security, legal, and marketing teams should establish:

• What information will be sent to the system, including prompts, uploaded files, logs, and feedback.
• Whether the vendor uses customer data to train or improve models, and whether that use can be disabled or otherwise controlled.
• Where data is stored, who can access it, how long it is retained, and how deletion works.
• How the vendor handles subcontractors, security incidents, access controls, and requested support.
• Whether the intended use is permitted under the BAA, organizational policies, and applicable HIPAA requirements.

Ask for specific contract and technical details rather than relying on a marketing claim or a general security certification. A vendor’s statement that it supports HIPAA does not establish that every feature, account type, or configuration is appropriate for PHI.

Consent, targeting, and tracking tools

HIPAA’s marketing rules and digital tracking practices deserve separate review. A campaign may use PHI only as permitted by the Privacy Rule, and certain marketing disclosures require an individual’s written authorization. Authorization requirements can depend on who is making the communication, what it promotes, and whether the covered entity receives payment from a third party. Get advice from the organization’s privacy or legal team before using patient lists for promotional targeting.

Tracking technologies on websites and apps can send information to analytics or advertising companies. The Department of Health and Human Services has issued guidance concerning online tracking, but legal requirements and their application can depend on the facts and current court decisions. Do not assume that a page is outside HIPAA just because it is public, or that a tracking vendor is harmless because the data is called “metadata.” Review the data collected, whether it can identify a person, and whether it reveals a relationship with a healthcare provider or sensitive service.

Where feasible, use aggregate or properly de-identified data for campaign analysis. HIPAA recognizes specific methods for de-identification, including expert determination and removal of specified identifiers, with conditions. Merely stripping direct identifiers or replacing names with codes is not automatically sufficient. De-identified information may still carry re-identification risk, so apply organizational review and appropriate controls.

Practical controls for marketing teams

A workable AI policy should turn privacy principles into everyday instructions. Consider a review process that covers the tool, use case, data, and people responsible:

1. Inventory AI tools and campaign workflows, including browser extensions, transcription services, chatbots, and agency platforms.
2. Classify inputs before use. Prohibit PHI in unapproved tools and provide staff with clear examples of information that must not be pasted into prompts.
3. Approve tools through privacy and security review; execute a BAA where required before PHI is handled.
4. Limit data to what the task needs, restrict access, and set retention and deletion practices.
5. Require human review of generated material for factual accuracy, privacy, misleading claims, bias, and inappropriate personalization.
6. Train staff and contractors, document approvals, and provide a route to report accidental disclosures or unexpected system behavior.

Keep a human accountable for campaign decisions. AI can produce fabricated clinical details, unsupported claims, or content that sounds individualized when it is not. Reviewers should check sources and claims, avoid implying that a person has a condition based on uncertain data, and make sure a chatbot does not present itself as a clinician or emergency service unless the organization has designed and governed that function appropriately.

Common misconceptions and consequences

“We removed the name” is not a reliable de-identification test. “The vendor signed a BAA” is not permission to use PHI for any purpose. And “the model only generated text” does not mean no disclosure occurred: the prompt, uploaded material, logs, or vendor processing may still contain PHI.

When a potential disclosure occurs, staff should promptly follow the organization’s incident-response process and notify the privacy or security officer. The Breach Notification Rule may require notices to affected individuals, HHS, and in some cases the media, depending on the circumstances. Do not independently decide that an incident is harmless or delay reporting while trying to investigate it alone. HIPAA penalties and other consequences depend on the facts; state privacy laws, contracts, and consumer-protection rules may also apply.

Frequently Asked Questions

Can healthcare marketers use ChatGPT or another public AI tool?
They may use a tool for general tasks that do not expose PHI, subject to workplace policy. Do not enter identifiable patient information into a public or otherwise unapproved tool. Confirm the service’s configuration, contract, and permitted data use before handling PHI.

Does a HIPAA-compliant AI tool make my campaign compliant?
No. The tool is only one part of the workflow. The campaign still needs a permitted purpose, appropriate authorization where required, access controls, staff review, and compliance with the organization’s policies and other applicable laws.

Can AI use patient data to personalize marketing?
Sometimes, but not automatically. Whether a use is allowed depends on the information, purpose, recipient, and HIPAA’s marketing and authorization rules. Have the privacy or legal team review the proposed use before building a patient-level audience.

Is de-identified patient data always safe to use?
No method eliminates every conceivable risk. HIPAA defines specific de-identification approaches, and the organization should confirm that the data meets the applicable standard and that its use follows policy and any relevant agreements.

What should we do if someone enters PHI into an unapproved AI tool?
Report it immediately through the organization’s incident process. Preserve relevant details, avoid further uploads, and let privacy and security staff assess the data, vendor handling, and any notification duties.

Related

• Single Sign-On (SSO) Explained Simply
• Oblivion Crash on Startup: Fixes That Work
• Subscription and Billing: How It Works